{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:01Z","timestamp":1781650741156,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic epiretinal membrane (iERM) is a common age-related vitreoretinal disorder characterized by fibrocellular proliferation on the inner limiting membrane. Although systemic inflammation has been suggested to play a potential role, the diagnostic value of systemic inflammatory indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) remains unclear. This study aimed to evaluate whether the relationships of iERM with clinical and hematological parameters, including age, gender, systemic inflammatory indices and common comorbidities, provide clinically significant additional information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective case\u2013control study included 59 patients with iERM and 56 healthy control subjects. The NLR, PLR, SII were compared between groups. Multivariable logistic regression analyses were performed to identify independent associations with iERM, and receiver operating characteristic (ROC) analyses were used to assess the discriminative performance of systemic inflammatory indices. An additional age-matched sensitivity analysis was conducted to address potential age-related confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with iERM were significantly older than controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). NLR, PLR, SII, neutrophil, lymphocyte, and platelet values showed no significant difference between groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). These findings remained consistent in the age-matched sensitivity analysis, in which 36 patients with iERM were matched to 36 controls, demonstrating no significant differences in systemic inflammatory indices or hematologic parameters between matched groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). Comorbidities such as diabetes mellitus and hypertension were not independently associated with iERM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.918). In multivariable logistic regression models, age remained the only independent predictor of iERM (Model-0: AUC\u2009=\u20090.723). The inclusion of NLR, PLR, or SII did not significantly improve model performance (AUC\u2009&lt;\u20090.02, higher AIC\/BIC, lower HL-p). ROC analyses demonstrated low discriminatory ability (NLR: 0.567, PLR: 0.522, SII: 0.568).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Confirming the limited clinical significance of these readily available biomarkers will be important to avoid unnecessary clinical use of such markers in iERM and present findings may help guide future research toward local retinal mechanisms rather than systemic inflammatory biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-04842-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:19:10Z","timestamp":1777025950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Limited clinical relevance of systemic inflammatory indices in idiopathic epiretinal membrane: a retrospective case\u2013control study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-6171","authenticated-orcid":false,"given":"Enes","family":"Toklu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-6727","authenticated-orcid":false,"given":"G\u00f6zde","family":"G\u00f6knar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1651-2943","authenticated-orcid":false,"given":"Seda Karaca","family":"Ad\u0131yeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"2","key":"4842_CR1","doi-asserted-by":"publisher","first-page":"e2881","DOI":"10.1016\/j.ajo.2005.03.032","volume":"140","author":"DJ McCarty","year":"2005","unstructured":"McCarty DJ, Mukesh BN, Chikani V, et al. Prevalence and associations of epiretinal membranes in the Visual Impairment Project. Am J Ophthalmol. 2005;140(2):e2881\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4842_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0161-6420(97)30190-0","volume":"104","author":"P Mitchell","year":"1997","unstructured":"Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes: the Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(6):1033\u201340.","journal-title":"Ophthalmology"},{"issue":"6","key":"4842_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2559.2011.03820.x","volume":"58","author":"M Kritzenberger","year":"2011","unstructured":"Kritzenberger M, Junglas B, Framme C, et al. Different collagen types define two types of idiopathic epiretinal membranes. Histopathology. 2011;58(6):953\u201365.","journal-title":"Histopathology"},{"issue":"6","key":"4842_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0161-6420(89)32811-9","volume":"96","author":"WE Smiddy","year":"1989","unstructured":"Smiddy WE, Maguire AM, Green WR, et al. Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. Ophthalmology. 1989;96(6):811\u201321.","journal-title":"Ophthalmology"},{"issue":"10","key":"4842_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00417-004-1019-3","volume":"242","author":"DR Snead","year":"2004","unstructured":"Snead DR, Cullen N, James S, et al. Hyperconvolution of the inner limiting membrane in vitreomaculopathies. Graefes Arch Clin Exp Ophthalmol. 2004;242(10):853\u201362.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"4842_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0008-4182(03)80023-6","volume":"38","author":"E Mandelcorn","year":"2003","unstructured":"Mandelcorn E, Khan Y, Javorska L, Cohen J, Howarth D, Mandelcorn M. Idiopathic epiretinal membranes: cell type, growth factor expression, and fluorescein angiographic and retinal photographic correlations. Can J Ophthalmol. 2003;38(6):457\u201363.","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"4842_CR7","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.1167\/iovs.10-7116","volume":"52","author":"L Iannetti","year":"2011","unstructured":"Iannetti L, Accorinti M, Malagola R, et al. Role of intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Invest Ophthalmol Vis Sci. 2011;52(8):5786\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4842_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.21037\/tlcr-20-997","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C, Yang H, Cai D, Xiang L, Fang W, Wang R. Preoperative peripheral blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio\u2013based nomograms predict survival in patients with limited-stage small-cell lung cancer. Transl Lung Cancer Res. 2021;10(2):866\u201378.","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"4842_CR9","first-page":"359","volume":"24","author":"C Ozgonul","year":"2016","unstructured":"Ozgonul C, Sertoglu E. Accurate use of neutrophil\/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm. 2016;24(3):359\u201360.","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"4842_CR10","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1097\/IJG.0000000000000392","volume":"25","author":"C Ozgonul","year":"2016","unstructured":"Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as novel biomarkers of primary open-angle glaucoma. J Glaucoma. 2016;25(10):e815\u2013e820.","journal-title":"J Glaucoma"},{"issue":"Suppl 2","key":"4842_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/annrheumdis-2014-eular.5121","volume":"73","author":"H Ryu","year":"2014","unstructured":"Ryu H, Lee M, Lee K, et al. Mean platelet volume is associated with Beh\u00e7et\u2019s disease activity. Ann Rheum Dis. 2014;73(Suppl 2):996\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4842_CR12","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4842_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5152\/balkanmedj.2015.15689","volume":"32","author":"O Polat","year":"2015","unstructured":"Polat O, Yavas GF, Inan S, Inan UU. Neutrophil-to-lymphocyte ratio as a marker in patients with non-arteritic anterior ischemic optic neuropathy. Balkan Med J. 2015;32(4):382\u20137.","journal-title":"Balkan Med J"},{"issue":"11","key":"4842_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/ICO.0000000000000260","volume":"33","author":"EE Karaca","year":"2014","unstructured":"Karaca EE, Ozmen MC, Ekici F, Yuksel E, Turkoglu Z. Neutrophil-to-lymphocyte ratio may predict progression in patients with keratoconus. Cornea. 2014;33(11):1168\u201373.","journal-title":"Cornea"},{"issue":"4","key":"4842_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10792-017-0597-0","volume":"38","author":"F Dikkaya","year":"2018","unstructured":"Dikkaya F, Karaman Erdur S, Ozsutcu M, Aydin R, Kocabora MS, Aras C. The significance of neutrophil-to-lymphocyte ratio in idiopathic epiretinal membrane. Int Ophthalmol. 2018;38(4):1393\u20137.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4842_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10792-020-01557-4","volume":"41","author":"D Uzlu","year":"2021","unstructured":"Uzlu D, Erd\u00f6l H, Somuncu AM, Ozbay AD, Kola M, Kose B. The role of simple inflammatory blood parameters in idiopathic epiretinal membrane patients. Int Ophthalmol. 2021;41(1):107\u201312.","journal-title":"Int Ophthalmol"},{"issue":"2","key":"4842_CR17","first-page":"218","volume":"53","author":"S Demircan","year":"2016","unstructured":"Demircan S, Yazici HU, Kahraman R, et al. Association of neutrophil-to-lymphocyte ratio with diabetic retinopathy in type 2 diabetic patients. Endocrine. 2016;53(2):218\u201325.","journal-title":"Endocrine"},{"issue":"3","key":"4842_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813\u201323.","journal-title":"Diabetes Care"},{"issue":"2","key":"4842_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"LE Bautista","year":"2005","unstructured":"Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19(2):149\u201354.","journal-title":"J Hum Hypertens"},{"issue":"9","key":"4842_CR20","doi-asserted-by":"publisher","first-page":"e014644","DOI":"10.1136\/bmjopen-2016-014644","volume":"7","author":"W Xiao","year":"2017","unstructured":"Xiao W, Chen X, Yan W, Zhu Z, He M. Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies. BMJ Open. 2017;7(9):e014644.","journal-title":"BMJ Open"},{"issue":"4","key":"4842_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2010.08.009","volume":"118","author":"CH Ng","year":"2011","unstructured":"Ng CH, Cheung N, Wang JJ, et al. Prevalence and risk factors for epiretinal membranes in a multiethnic United States population. Ophthalmology. 2011;118(4):694\u20139.","journal-title":"Ophthalmology"},{"key":"4842_CR22","first-page":"251584142110105","volume":"13","author":"G Demir","year":"2021","unstructured":"Demir G, Topcu H, Cakmak S, et al. Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume in patients with idiopathic epiretinal membrane. Ther Adv Ophthalmol. 2021;13:25158414211010546.","journal-title":"Ther Adv Ophthalmol"},{"issue":"26","key":"4842_CR23","doi-asserted-by":"publisher","first-page":"e34225","DOI":"10.1097\/MD.0000000000034225","volume":"102","author":"G Qin","year":"2023","unstructured":"Qin G, Lin T, You Y, Shang M, He W, Pazo EE. Blood inflammatory biomarkers in participants with idiopathic epiretinal membrane: A retrospective case series study. Medicine. 2023;102(26):e34225.","journal-title":"Medicine"},{"issue":"2","key":"4842_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"L Bautista","year":"2005","unstructured":"Bautista L, Vera L, Arenas I, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-\u03b1) and essential hypertension. J Hum Hypertens. 2005;19(2):149\u201354.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"4842_CR25","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/dia.2013.0097","volume":"15","author":"SM Ulu","year":"2013","unstructured":"Ulu SM, Dogan M, Ahsen A, Altug A, Demir K, Acart\u00fcrk G, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15(11):942\u20137.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"4842_CR26","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1167\/iovs.14-15971","volume":"56","author":"S-C Bu","year":"2015","unstructured":"Bu S-C, Kuijer R, van der Worp RJ, Postma G, De Lavalette VWR, Li X-R, et al. Immunohistochemical evaluation of idiopathic epiretinal membranes and in vitro studies on the effect of TGF-\u03b2 on M\u00fcller cells. Investig Ophthalmol Vis Sci. 2015;56(11):6506\u201314.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"4842_CR27","first-page":"192582","volume":"2013","author":"M Joshi","year":"2013","unstructured":"Joshi M, Agrawal S, Christoforidis JB. Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediat Inflamm. 2013;2013(1):192582.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"4842_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12886-019-1200-4","volume":"19","author":"Y Hu","year":"2019","unstructured":"Hu Y, Cheng Y, Xu X, et al. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab. BMC Ophthalmol. 2019;19(1):194.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"4842_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/09273948.2014.921715","volume":"23","author":"N Ilhan","year":"2015","unstructured":"Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of neutrophil\/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm. 2015;23(4):287\u201390.","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"4842_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/dia.2013.0097","volume":"15","author":"SM Ulu","year":"2013","unstructured":"Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15(11):942\u20137.","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"4842_CR31","doi-asserted-by":"publisher","first-page":"e0164355","DOI":"10.1371\/journal.pone.0164355","volume":"11","author":"S Myojin","year":"2016","unstructured":"Myojin S, Yoshimura T, Yoshida S, et al. Gene expression analysis of irrigation solution samples collected during vitrectomy for idiopathic epiretinal membrane. PLoS ONE. 2016;11(10):e0164355.","journal-title":"PLoS ONE"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04842-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:40:05Z","timestamp":1781649605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04842-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Bak\u0131r\u00e7ay University Ethics Committee (approval number: 2024\/1860). All procedures were performed in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}